Baird’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$5.22M Sell
75,247
-2,126
-3% -$147K 0.05% 337
2014
Q4
$5.35M Buy
77,373
+5,101
+7% +$345K 0.06% 318
2014
Q3
$4.71M Buy
72,272
+16,616
+30% +$1.1M 0.07% 260
2014
Q2
$3.79M Sell
55,656
-3,095
-5% -$207K 0.05% 317
2014
Q1
$3.81M Buy
58,751
+1,972
+3% +$124K 0.06% 328
2013
Q4
$3.7M Buy
56,779
+461
+0.8% +$29.5K 0.06% 329
2013
Q3
$3.34M Buy
56,318
+1,767
+3% +$105K 0.06% 335
2013
Q2
$3.13M Buy
+54,551
New +$3.24M 0.06% 324

Other funds holding CL

Baird's CL Position: Q1 2015 in Review

Baird reduced its Colgate-Palmolive (CL) stake by 2.7% in Q1 2015, selling an estimated $147K and leaving 75,247 shares worth $5.22M. The position accounts for 0.05% of the portfolio, ranked #337.

Baird first reported a position in CL in Q2 2013 and has held it in 8 quarters since. The position peaked at $5.35M in Q4 2014. 1,227 funds tracked by Wall St. Rank hold CL as of Q1 2015.

  • Baird held 75,247 shares of Colgate-Palmolive worth $5.22M as of Q1 2015.
  • Baird sold 2,126 Colgate-Palmolive shares in Q1 2015, an estimated $147K.
  • Colgate-Palmolive made up 0.05% of Baird's portfolio in Q1 2015, its #337 holding.
  • Baird first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 8 quarters since.
  • Baird's Colgate-Palmolive position peaked at $5.35M in Q4 2014.
  • 1,227 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.